21 May 2019
Humira tops the list despite growing biosimilar competition, while Opdivo and Keytruda, the new-age checkpoint inhibitors for cancer have grown in terms of market share and revenue generation since their...
10 May 2019
With one of the strongest and most productive life sciences sectors currently operating the UK is a world leader in manufacturing and marketing clinical products and pharmaceuticals. There are over...
21 November 2018
In this issue: China’s growing pharmaceutical market, antimicrobial resistance, the rise of tech giants in healthcare, and more.
20 September 2018
In this issue: Making manufacturing work in gene and cell therapies, AI generated compounds, clinical trial transparency in the Americas, and more.
19 July 2018
In this issue: Major investment signals confidence in the search for new products developed from DNA found in soil, a medical milestone for cannabinoids in the US, streamlining clinical research,...
27 June 2018
In this issue: Overcoming red tape in China, how to boost adoption of biosimilars in the US, a profile of global health research network TriNetX, unlocking cell-free protein synthesis, and...
27 February 2018
In this issue: The benefits of seamless clinical trials, a new functional cure for HIV, using mRNA to target cancer tumours, the potential of magnetic hyperthermia in killing cancerous cells,...
24 January 2018
In this issue: How cancer drug resistance works, accessing funding for rare diseases, India’s attempt to redefine over the counter drugs, the biotech potential of slipper limpets, Dundee University’s influence...